Our latest research showing hnRNP A1 dysfunction alters RNA splicing and drives neurodegeneration in multiple sclerosis (MS) has just been published with Springer Nature in Nature Communications! In this article, advanced RNA sequencing and CLIPseq of MS brains and relevant models demonstrate that hnRNP A1 binding of target RNAs and RNA splicing were altered, precipitating neurodegeneration in MS. Read it here: https://rdcu.be/dvqwA
Congratulations to our summer medical student, Dr. Cole Libner, on winning the Whitaker Award at the Consortium of Multiple Sclerosis Centers (CMSC) Conference in Nashville, TN for Best Trainee Research Presentation!
Congratulations to Dr. Michael Levin on being awarded Provincial Medical Researcher of the Year!
Congratulations to our undergraduate honour's student, Kaitland Fior, and PhD student, Miranda Messmer, who both won awards at the USask 2024 Life & Health Sciences Research Expo! Kaitland won 1st place in the Undergraduate 1 category and Miranda won 2nd place in the Basic Science 2 category.
Congratulations to our honour's project student, Kaitland Fior, on winning an NSERC Undergraduate Student Research Award for her upcoming summer research project!
Congratulations to Dr. Levin for being selected to give a TEDx talk at USASK on January 21, 2024.
Congratulations to our summer students, Kaitland Fior and Jake Hesselink, who both won awards at the 2023 Undergraduate Research Showcase!
Congratulations to our graduate student, Miranda Messmer, on being awarded the Raifta Shwedyk Bursary Fund! This bursary makes a donation toward the endMS National Training Program to sponsor a student trainee attending the endMS Summer School from a university in Manitoba or Saskatchewan.
Congratulations to our Professional Research Associate, Dr. Hannah Salapa, on winning the 10X Genomics Single Cell Grant competition! This grant is funded by 10X Genomics and the University of Saskatchewan Next-Generation Sequencing Facility to support creative and innovative single cell sequencing pilot projects.
Congratulations to Dr. Cole Libner on being selected as a Foundation of the Consortium of Multiple Sclerosis Centers Research Scholar! Cole completed his PhD with us last year before starting medical school at the University of Saskatchewan. He has returned to the lab this summer to complete a research project titled, "Novel small molecule therapy to inhibit neurodegeneration in an in vivo model of multiple sclerosis."
Congratulations to our post-doctoral fellow, Dr. Joseph P. Clarke, on the acceptance of his paper titled, "Sequence- and structure-specific RNA oligonucleotide binding attenuates heterogeneous nuclear ribonucleoprotein A1 dysfunction" to the journal Frontiers in Molecular Biosciences! In a cellular model that imitates aspects of MS, Dr. Clarke and colleagues demonstrated that RNA oligonucleotides attenuate heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) dysfunction and its detrimental downstream cellular effects. This is important because hnRNPA1 dysfunction has been shown to contribute to the pathogenesis of MS and using RNA oligonucleotides to disrupt hnRNPA1 dysfunction may be used as a treatment for MS.
Congratulations to Drs. Hannah Salapa and Sarah Donkers on winning the Royal University Hospital Foundation ‘Women Leading Philanthropy’ grant for their proposal titled, “New Hope in MS: Promoting Functional Neurorecovery Through Early Intervention”!
Dr. Michael Levin, professor of neurology at the University of Saskatchewan, discussed his presentation at the 2022 CMSC Annual Meeting on using ribonucleoprotein A1 antibodies to drive neurodegeneration in multiple sclerosis.
The province of Saskatchewan has some of the highest rates of Multiple Sclerosis in Canada. A recent study that was published in the Journal of Science states that the Epstein-Barr virus (which causes mononucleosis) or mono, acts as an environmental trigger for Multiple Sclerosis. Dr. Michael Levin, the Saskatchewan MS Clinical Research Chair and professor at the University of Saskatchewan joins us live in Studio to answer all MS related questions.
https://thestarphoenix.com/news/local-news/qa-sask-doc-breaks-down-ms-discovery?fbclid=IwAR2wgtnNqpuGQ5LVonlcgyFTjmFlL-55RnxekFKMSdaYljbsODtaIsnOQUc
Congratulations to our summer student, Todd Stang, on winning 3rd Place at the Student Undergraduate Research Experience Summer Symposium! Todd's project is titled, "Exploring the Role of Nucleocytoplasmic Transport Changes in Neuronal Cell Damage in Models of Nervous System Disease."
Congratulations to our Research Assistant, Dr. Patricia Thibault, who recently published a review article titled, "hnRNP A/B Proteins: An Encyclopedic Assessment of Their Roles in Homeostasis and Disease" in Biology!
In a hands-on, knowledge translation (KT) research experience, persons living with MS help MS researchers with an important study on upper extremity function. Both the KT and MS research study were published in ‘MS International’ – a journal that specifically addresses MS.
Dr. Levin answers questions and shares information on a federal funding his team has received that will be used for MS research.
On May 31, the University of Saskatchewan put out a media release announcing recently funded research projects.
Dr. Levin answers questions and discusses the latest research and some breakthroughs made in the past year.
Canadian Country Artist- Jess Moskaluke was joined by Dr. Levin for an in-depth discussion about all things MS and new lab discoveries
Cole Libner, University of Saskatchewan student and team member in the Office of the Saskatchewan MS Clinical Research Chair, is among the successful applicants for the endMS Scholar Program for Researchers IN Training (SPRINT).
Dr. Levin discusses MAD4MS Comedy Night Fundraiser, and his teams latest work and discoveries in MS Research
Dr. Levin discusses his teams latest work and discoveries in MS Research.
The University of Saskatchewan multiple sclerosis research team was the recipient of a unique fundraising event earlier this year
The StarPhoenix spoke with Saskatchewan multiple sclerosis clinical research chair, Dr. Michael Levin, about some of the new developments in MS research at the University of Saskatchewan.
Hannah Salapa, received the 2019 Whitaker Track Research Award at the annual meeting of the Consortium on Multiple Sclerosis (MS) Centers, May 31, in Seattle.
Dr. Levin answers questions and discusses the latest research and some breakthroughs made in the past year.
Why do people with multiple sclerosis get worse? Researcher Dr. Michael Levin and his team at U of S have made a ground-breaking discovery to help answer that question.
A research team of five scientists at the University of Saskatchewan has made what's being called a ground-breaking discovery. It could, in time, mean a change in treatment for people who suffer from multiple sclerosis.
On September 12, the University of Saskatchewan put out a media release announcing Dr. Levin's most recent discovery.
A discovery at the University of Saskatchewan could pave the way for research into new drugs that could potentially slow or reverse the course for patients with Multiple Sclerosis.
For World MS Day, CBC Saskatchewan conducted a live Facebook interview with Dr. Levin and Erin Kuan
Dr. Levin was interviewed by John Gormley about Multiple Sclerosis in Saskatchewan
University of Saskatchewan Awards Announcement
University of Saskatchewan researchers try to uncover reasons for disease's prevalence in the Prairies
Dr. Poliakov discusses recent publication of study results of Dr. Zimbardo's "liberation treatment".
Dr. Levin was interviewed by CBC's Bridget Yard regarding the recent publication of Dr. Zimbardo's "liberation treatment".
Dr. Michael Levin will take on a seven-year term as the university’s new $8.4-million chair in multiple sclerosis research beginning in March, the school announced Thursday.
